U.S. Silica to Participate in Upcoming Investor Conferences
Get Alerts SLCA Hot Sheet
Join SI Premium – FREE
FREDERICK, Md., Oct. 30, 2017 /PRNewswire/ -- U.S. Silica Holdings, Inc. (NYSE: SLCA) today announced that members of the management team will participate in the following investor conferences and events during the fourth quarter of 2017:

Credit Suisse European Non-Deal Roadshow Nov. 14-15, 2017 – London, U.K. Nov. 16, 2017 – Zurich/Geneva, Switzerland
2017 Jefferies Energy Conference Nov. 28, 2017 St. Regis Hotel – Houston, TX
2017 Cowen 7th Annual Energy & Natural Resources Conference Dec. 4, 2017 Le Parker Meridien New York – New York, NY
Management will meet with institutional investors throughout these events. Please note, when applicable, the presentations will be posted on the Company's website prior to the start of each event at www.ussilica.com.
About U.S. Silica
U.S. Silica Holdings, Inc., a member of the Russell 2000, is a leading producer of commercial silica used in the oil and gas industry, and in a wide range of industrial applications. Over its 117-year history, U.S. Silica has developed core competencies in mining, processing, logistics and materials science that enable it to produce and cost-effectively deliver over 260 products to customers across our end markets. The Company currently operates nine industrial sand production plants and eight oil and gas sand production plants. The Company is headquartered in Frederick, Maryland and also has offices located in Chicago, Illinois and Houston, Texas.
U.S. Silica Holdings, Inc. Michael Lawson Vice President of Investor Relations and Corporate Communications 301-682-0304 [email protected]
Nick Shaver Investor Relations Manager 281-394-9630 [email protected]
View original content with multimedia:http://www.prnewswire.com/news-releases/us-silica-to-participate-in-upcoming-investor-conferences-300545829.html
SOURCE U.S. Silica Holdings, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Small Essential, Big Difference: How Modofo Makes Everyday Drinkware More Stylish
- Memecoin AI Agent Trading 2026: How MemeToro Could Redefine Automated Crypto Launches
- Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Credit Suisse, Jefferies & Co, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share